Opthea Announces Decision to Discontinue Wet AMD Trials

Stock Information for Opthea Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Opthea Limited

Opthea Announces COAST Phase 3 Trial Topline Results
Opthea Announces Phase 2b Wet AMD Publication
Opthea Reports Half Year Results and Business Updates
Opthea Completes Drug Product PPQ Campaign
Opthea Completes COAST Final Week 52 Patient Visit
Opthea to Present at Oppenheimer Healthcare Conference
Opthea Wet AMD Data Featured at Macula Society Meeting
Opthea to Host Investor Days in New York and Australia

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.